Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-3523PMID 16618760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal

  2005cited by this paper
• Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.

  2005cited by this paper
• Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs.

  2005cited by this paper
• Modulation of CSF-1-regulated post-natal development with anti-CSF-1 antibody.

  2005influential reference
• An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants

  2005cited by this paper
• Colony-Stimulating Factor-1 Blockade by Antisense Oligonucleotides and Small Interfering RNAs Suppresses Growth of Human Mammary Tumor Xenografts in Mice

  2004influential reference
• CSF-1 regulation of the wandering macrophage: complexity in action.

  2004influential reference
• Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

  2003cited by this paper
• MT1-MMP and MMP-7 in invasion and metastasis of human cancers

  2003cited by this paper
• M-CSF Induces Vascular Endothelial Growth Factor Production and Angiogenic Activity From Human Monocytes 1

  2003cited by this paper
• The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies

  2002cited by this paper
• Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.

  2002cited by this paper
• Stromal Effects on Mammary Gland Development and Breast Cancer

  2002cited by this paper
• Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice.

  2002influential reference
• Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms.

  2002cited by this paper
• Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis.

  2001cited by this paper
• Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy

  2001cited by this paper
• The Pathway of Neoplastic Transformation of Human Breast Epithelial Cells

  2001cited by this paper
• Cytokine reference : a compendium of cytokines and other mediators of host defence

  2001influential reference
• The microenvironment of the tumour–host interface

  2001cited by this paper
• Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.

  2001cited by this paper
• Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.

  2001cited by this paper
• Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.

  2000cited by this paper
• Postnatal mammary gland development requires macrophages and eosinophils.

  2000cited by this paper
• Mild preconditioning and low-level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.

  2000cited by this paper
• The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

  1999cited by this paper
• Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.

  1999cited by this paper
• Macrophage Colony-Stimulating Factor (CSF-1)

  1998cited by this paper
• CSF‐1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract

  1997cited by this paper
• CSF-1 treatment promotes angiogenesis in the metaphysis of osteopetrotic (toothless, tl) rats.

  1995cited by this paper
• Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity.

  1995cited by this paper
• Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis.

  1994cited by this paper
• Colony stimulating factor 1 is required for mammary gland development during pregnancy.

  1994cited by this paper
• Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse.

  1994cited by this paper
• Additive effects of interleukin 1 and tumour necrosis factor‐alpha on the accumulation of the three granulocyte and macrophage colony‐stimulating factor mRNAs in human endothelial cells.

  1987cited by this paper
• Regulation of colony-stimulating factor 1 during pregnancy

  1986cited by this paper

• Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC

  2025cites this paper
• Research progress on monocyte/macrophage in the development of gastric cancer.

  2025cites this paper
• An oral heme oxygenase inhibitor targets immunosuppressive perivascular macrophages in preclinical models of cancer

  2025cites this paper
• Omega-3 fatty acids: molecular weapons against chemoresistance in breast cancer

  2025cites this paper
• M1 macrophages enhance breast cancer chemoresistance via JAK-STAT3 signaling.

  2025cites this paper
• Therapeutic advances in Tenosynovial giant cell Tumor: Targeting the CSF1/CSF1R axis.

  2025cites this paper
• The role of macrophages in oral cancer: A narrative review

  2025cites this paper
• HOXC6 promotes the metastasis of MSI-H CRC by interacting with M2 macrophages and inducing effector T cell exhaustion

  2025cites this paper
• ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype

  2024cites this paper
• Integrins and Integrin-Driven Secretory Pathways as Multi-dimensional Regulators of Tumor-Associated Macrophage Recruitment and Reprogramming in Tumor Microenvironment.

  2024cites this paper
• Sialic acid-modified docetaxel cationic liposomes: double targeting of tumor-associated macrophages and tumor endothelial cells

  2024cites this paper
• A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis.

  2024cites this paper
• The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer

  2024cites this paper
• A review concerning the breast cancer-related tumour microenvironment.

  2024cites this paper
• Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy

  2024cites this paper
• Targeting tumor-associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)

  2024cites this paper
• Chemotherapy Enriches for Proinflammatory Macrophage Phenotypes that Support Cancer Stem-Like Cells and Disease Progression in Ovarian Cancer

  2024cites this paper
• The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited

  2023cites this paper
• Constructing 3D In Vitro Models of Heterocellular Solid Tumors and Stromal Tissues Using Extrusion-Based Bioprinting.

  2023cites this paper
• Biofilm Potentiates Cancer-Promoting Effects of Tumor-Associated Macrophages in a 3D Multi-Faceted Tumor Model.

  2023cites this paper
• LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer.

  2023cites this paper
• Recent Advances and Mechanism of Nanomaterials Promoting Tumor Metastasis

  2023cites this paper
• Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects

  2022cites this paper
• Repolarization of Unbalanced Macrophages: Unmet Medical Need in Chronic Inflammation and Cancer

  2022cites this paper
• Perivascular macrophages collaborate to facilitate chemotherapy resistance in cancer

  2022cites this paper
• The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance

  2022cites this paper
• Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies

  2022cites this paper
• Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance

  2022cites this paper
• Macrophages as tools and targets in cancer therapy

  2022cites this paper
• Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies

  2022cites this paper
• Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and Neutrophils

  2022cites this paper
• Tumour-associated macrophages heterogeneity drives resistance to clinical therapy

  2022cites this paper
• Tumor microenvironment promotes breast cancer chemoresistance

  2021cites this paper
• Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer

  2021cites this paper
• Taxanes in cancer treatment: Activity, chemoresistance and its overcoming.

  2021cites this paper
• Cellular Indoctrination: How the Tumor Microenvironment Reeducates Macrophages Towards Nefarious Ends

  2021cites this paper
• Targeting Tumor Microenvironment Through Nanotheranostics

  2021cites this paper
• Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

  2021cites this paper
• Abraxane-induced bone marrow CD11b+ myeloid cell depletion in tumor-bearing mice is visualized by μPET-CT with 64Cu-labeled anti-CD11b and prevented by anti-CSF-1

  2021cites this paper
• Construction of the Prediction Model for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy Based on Pretreatment Tumor-Infiltrating Macrophage-Associated Biomarkers

  2021cites this paper
• A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications

  2021cites this paper
• Identification of immune-related biomarkers for predicting neoadjuvant chemotherapy sensitivity in HER2 negative breast cancer via bioinformatics analysis.

  2021cites this paper
• Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors.

  2021cites this paper
• Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses

  2021cites this paper
• Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis

  2021cites this paper
• Tumor-Associated Macrophages: A Potential Target for Cancer Therapy

  2021cites this paper
• Heterogeneous Myeloid Cells in Tumors

  2021cites this paper
• A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

  2021cites this paper
• Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy

  2021cites this paper
• Tumor-associated myeloid cells: diversity and therapeutic targeting

  2021cites this paper
• Macrophage-mediated cancer drug delivery

  2020cites this paper
• Targeting tumor‐associated macrophages: A potential treatment for solid tumors

  2020cites this paper
• The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor Microenvironment

  2020cites this paper
• Upregulation of CSF-1 is correlated with elevated TAM infiltration and poor prognosis in oral squamous cell carcinoma.

  2020cites this paper
• HOXC6 Promotes Metastasis of MSI-H CRC via Interacting with M2 Macrophages

  2020cites this paper
• MicroRNAs: As Critical Regulators of Tumor- Associated Macrophages

  2020cites this paper
• Extracellular-Regulated Protein Kinase 5-Mediated Control of p21 Expression Promotes Macrophage Proliferation Associated with Tumor Growth and Metastasis

  2020cites this paper
• Tumor-associated macrophages in lung cancer: Friend or foe?

  2020cites this paper
• Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers

  2020cites this paper
• Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast Cancer

  2020cites this paper
• Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.

  2020cites this paper
• A blocking antibody against canine CSF-1R maturated by limited CDR mutagenesis

  2020cites this paper
• Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.

  2020cites this paper
• Interplay between inflammation and cancer.

  2020cites this paper
• Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments.

  2019cites this paper
• Tailoring Nanomaterials for Targeting Tumor‐Associated Macrophages

  2019cites this paper
• Interaction of tumor-associated macrophages and cancer chemotherapy

  2019cites this paper
• Targeting Tumor-Associated Macrophages in Cancer.

  2019cites this paper
• Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response

  2019cites this paper
• Chemotherapy-Induced Metastasis: Molecular Mechanisms, Clinical Manifestations, Therapeutic Interventions.

  2019cites this paper
• The emerging roles of macrophages in cancer metastasis and response to chemotherapy

  2019cites this paper
• Tumor-associated macrophages: an accomplice in solid tumor progression

  2019cites this paper
• Macrophages in Colorectal Cancer Liver Metastases

  2019cites this paper
• Macrophages at the crossroads of anticancer strategies.

  2019cites this paper
• M-CSF on hypoxia-inducible factor-1α (HIF-1α)/BCL2/adeno- virus E1B 19 kDa-interacting protein 3 (BNIP3)/Apoptosis Regulator BAX signalling in human breast cancer MCF-7 cells were investigated. Western blotting revealed that the expression of HIF-1α, BNIP3, Bax, caspase-3 and caspase-9 was lower in

  2019cites this paper
• Monocytes and cancer: promising role as a diagnostic marker and application in therapy

  2019cites this paper
• Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer

  2018cites this paper
• Targeting macrophages: therapeutic approaches in cancer

  2018cites this paper
• Shock wave treatment after hindlimb ischaemia results in increased perfusion and M2 macrophage presence

  2018cites this paper
• Tumor-associated macrophages in breast cancer: Innocent bystander or important player?

  2018cites this paper
• THE IMPACT OF HISTAMINE RECEPTOR 2 ANTAGONISTS ON BREAST CANCER DEVELOPMENT AND MONOCYTIC POPULATIONS

  2018cites this paper
• Molecular Repolarisation of Tumour-Associated Macrophages

  2018cites this paper
• Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance

  2018cites this paper
• Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes

  2018cites this paper
• Targeting Macrophages in Cancer: From Bench to Bedside

  2018cites this paper
• Translational Research in Breast Cancer

  2017cites this paper
• Tumor-Associated Macrophages as Target for Antitumor Therapy

  2017cites this paper
• Tumor Microenvironment and Differential Responses to Therapy.

  2017cites this paper
• Innate immune cells for immunotherapy of autoimmune and cancer disorders

  2017cites this paper
• Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges

  2017cites this paper
• Macrophage Polarization: Anti‐Cancer Strategies to Target Tumor‐Associated Macrophage in Breast Cancer

  2017cites this paper
• Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.

  2017cites this paper
• Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis

  2017cites this paper
• Tumor microenvironment and therapeutic response.

  2017cites this paper
• Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy

  2017influential citation
• Fonctions nucléaires du récepteur de CSF-1 dans les monocytes humains

  2017cites this paper
• The Promise of Targeting Macrophages in Cancer Therapy

  2017cites this paper
• MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer

  2017cites this paper
• Exploring the Impact of Doxorubicin on the Perivascular Niche in Cancer

  2017cites this paper
• VPS34 stimulation of p62 phosphorylation for cancer progression

  2017cites this paper